Misuse of substitution drugs in the substitution-based therapy
Saved in:
Bleckwenn, M., et al., Misuse of substitution drugs in the substitution-based therapy. European Addiction Research, vol. 22, n. 6, 2016, p. 322-328.
Ref.
517217
Location:
SIIS R.1142
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Reducción de daños, Programas de mantenimiento, Fármacos, Tratamiento médico, Tráfico de drogas, Metadona, Buprenorfina, Alternativas, Alemania
Drogodependencias, Drogas ilegales, Opiáceos, Reducción de daños, Programas de mantenimiento, Fármacos, Tratamiento médico, Tráfico de drogas, Metadona, Buprenorfina, Alternativas, Alemania
Similar Items: Misuse of substitution drugs in the substitution-based therapy
- Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors
- Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany
- BUPRENORPINE SNIFFING AS A RESPONSE TO INADEQUATE CARE IN SUBSTITUTED PATIENS: RESULTS FROM THE SUBAZUR SURVEY IN SOUTH EASTERN FRANCE
- Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients’ attitudes and norms
- OPIOID SUBSTITUTION WITH METHADONE AND BUPRENORPHINE: SEXUAL DYSFUNCTION AS A SIDE EFFECT OF THERAPY
- NATIONAL OPIOID SUBSTITUTION TREATMENT PROVIDERS TRAINING PROGRAMME